KPV 2mg — Vial Spec, Reconstitution Math & COA
A 2mg vial of KPV provides high-purity Lysine-Proline-Valine tripeptide engineered specifically for low-throughput in vitro assays and small-cohort rodent experiments. This guide details the physical parameters, reconstitution concentration calculations, storage protocols, and quality verification standards necessary for precise laboratory research. While researchers frequently utilize 2mg configurations for short-term pilot studies, PX1 Research maintains flexible catalog inventory including larger unit sizes to support scalable experimental designs.
Quick answer
A 2mg vial of KPV provides high-purity Lysine-Proline-Valine tripeptide engineered specifically for low-throughput in vitro assays and small-cohort rodent experiments. This guide details the physical parameters, reconstitution concentration calculations, storage protocols, and quality verification standards necessary for precise laboratory research. While researchers frequently utilize 2mg configurations for short-term pilot studies, PX1 Research maintains flexible catalog inventory including larger unit sizes to support scalable experimental designs.
Key takeaways
- A 2mg vial of [KPV](/research-peptides/kpv) contains 2 milligrams of lyophilized Lysine-Proline-Valine (C16H30N4O4), a C-terminal tripeptide fragment derived from alpha-melanocyte-stimulating hormone (alpha-MSH).
- [KPV](/research-peptides/kpv) is a short, biologically active peptide sequence comprising Lysine, Proline, and Valine.
- The primary focus of preclinical literature surrounding [KPV](/research-peptides/kpv) centers on intestinal inflammation and mucosal barrier integrity.
- Accurate reconstitution requires calculating the final working concentration based on the volume of diluent introduced into the 2mg sealed vial.
Overview of the KPV 2mg Vial Specification
A 2mg vial of KPV contains 2 milligrams of lyophilized Lysine-Proline-Valine (C16H30N4O4), a C-terminal tripeptide fragment derived from alpha-melanocyte-stimulating hormone (alpha-MSH). In molecular biology and preclinical pharmacology, this specific fill size is typically selected by investigators running low-volume cell culture assays, localized tissue permeability screens, or brief pilot studies in rodent models. The 2mg format allows researchers to work with freshly reconstituted peptide solutions while minimizing the risk of degradation associated with repeated freeze-thaw cycles of larger bulk stock.
PX1 Research manufactures and packages research-grade peptides in ISO 17025-accredited, GMP-compliant facilities within the United States. While specialized low-dose pilot projects occasionally demand a 2mg fill, institutional laboratories requiring higher volumetric throughput or multi-arm animal studies often opt for larger options. Please note that if the 2mg format is currently out of stock or reserved for custom institutional orders, PX1 Research provides fully verified alternatives directly through our catalog, such as our standard KPV 10mg vial size. Researchers can review our complete inventory across all product categories via the all peptides catalog page.
Chemical Structure and Anti-Inflammatory Pathways
KPV is a short, biologically active peptide sequence comprising Lysine, Proline, and Valine. Despite lacking the full amino acid chain of parent alpha-MSH, preclinical studies suggest that KPV retains robust anti-inflammatory properties without activating classical melanocortin receptors (such as MC1R or MC4R) responsible for pigmentation or metabolic regulation. Its primary mechanism of action relies on intracellular entry and nuclear translocation, where it directly interacts with key signaling cascades.
In vitro data indicate that KPV enters target cells via the peptide transporter PEP11 (SLC15A4) and translocates to the nucleus. Once intracellular, KPV modulates the nuclear factor kappa B (NF-κB) pathway by inhibiting the phosphorylation and nuclear translocation of the p65 subunit. This inhibition suppresses the downstream transcription of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). Because of these targeted anti-inflammatory signaling events, KPV serves as a crucial molecular tool for dissecting non-melanocortin-dependent pathways in immune and epithelial biology.
Preclinical Research in Intestinal Barrier and Colitis Models
The primary focus of preclinical literature surrounding KPV centers on intestinal inflammation and mucosal barrier integrity. In animal models of experimental colitis—such as dextran sulfate sodium (DSS)-induced or trinitrobenzene sulfonic acid (TNBS)-induced inflammatory bowel disease (IBD)— KPV administration has demonstrated marked reductions in mucosal ulceration, myeloperoxidase (MPO) activity, and leukocyte infiltration.
Furthermore, cell culture models employing Caco-2 human intestinal epithelial monolayers show that KPV preserves tight junction architecture under inflammatory challenge. By preventing the breakdown of key structural proteins such as zonula occludens-1 (ZO-1) and occludin, KPV helps maintain transepithelial electrical resistance (TEER). Researchers utilizing kpv 2mg vials frequently study these cellular transport kinetics, evaluating how micro-molar concentrations of the tripeptide preserve epithelial membrane dynamics in vitro.
Reconstitution Mathematics for a 2mg KPV Vial
Accurate reconstitution requires calculating the final working concentration based on the volume of diluent introduced into the 2mg sealed vial. Standard laboratory diluents include Bacteriostatic Water (0.9% benzyl alcohol) for multi-use analytical protocols or sterile 0.9% Sodium Chloride (saline) for immediate cell culture applications. Investigators should select the diluent volume that best aligns with their pipetting accuracy requirements and target assay concentrations.
Below are the standard volumetric yield calculations when reconstituting a 2mg lyophilized cake of KPV: • **1.0 mL Diluent Addition:** Yields a final concentration of 2.0 mg/mL (2.0 µg/µL). This higher concentration is optimal for micro-aliquoting or high-density cell treatment assays. • **2.0 mL Diluent Addition:** Yields a final concentration of 1.0 mg/mL (1.0 µg/µL). This 1:1 ratio simplifies dose-calculation math in microplate protocols. • **3.0 mL Diluent Addition:** Yields a final concentration of 0.667 mg/mL (approx. 0.67 µg/µL). Suitable for lower-concentration working solutions where larger liquid volumes are preferred for dispensing accuracy. To perform custom volumetric or molarity conversions, researchers should utilize our interactive reconstitution calculator tool.
Laboratory Handling, Aliquot Planning, and Storage Guidelines
Maintaining peptide integrity requires strict adherence to laboratory cold-chain protocols. Lyophilized KPV standard vials should be stored at -20°C upon receipt in a manual defrost freezer, protected from light and moisture. Under these conditions, the desiccated cake remains stable for up to 24 months. Prior to reconstitution, vials must be allowed to equilibrate to room temperature for 20–30 minutes to prevent condensation from forming inside the vial upon stopper puncture.
Once reconstituted with an appropriate sterile diluent, KPV solution should be gently swirled rather than vortexed to avoid shear stress on the peptide molecules. For short-term experimental work, reconstituted solutions may be kept at 4°C for up to 7–14 days if prepared with bacteriostatic water. For long-term utility, the reconstituted stock should be divided into single-use micro-aliquots in polypropylene low-binding tubes and frozen at -80°C. Avoid repeating freeze-thaw cycles, as cyclic phase changes induce molecular aggregation and diminish biological activity.
Analytical Quality Standards: HPLC, MS, and COA Issuance
PX1 Research implements rigorous quality control testing for every manufacturing batch. Regardless of whether a lot is dispensed into 2mg or 10mg vials, each fill lot undergoes comprehensive identity and purity verification. High-Performance Liquid Chromatography (HPLC) is conducted to verify chromatographic purity, ensuring that every batch meets or exceeds our baseline requirement of 98.0%. Liquid Chromatography-Mass Spectrometry (LC-MS) confirms the precise molecular weight of the KPV tripeptide (342.42 g/mol), ruling out truncated sequences or residual synthesis side-products.
In addition to purity and identity confirmation, PX1 Research subjects all batches to quantitative bacterial endotoxin testing (LAL assay) to guarantee suitability for sensitive cell culture and animal tissue protocols. Every shipment is backed by a downloadable, lot-matched Certificate of Analysis. Researchers can independently verify batch metrics, HPLC chromatograms, and mass spectra by visiting our dedicated COA lookup page.
Comparative Analysis: KPV vs. Complementary Research Peptides
In experimental models evaluating barrier repair and tissue homeostasis, KPV is frequently studied alongside or compared against other prominent research peptides. While KPV specifically modulates NF-κB nuclear translocation and cellular transport via PEP11, other compounds operate through distinct biological pathways. Understanding these mechanical differences allows investigators to select the appropriate compound—or multi-peptide panel—for their specific research objectives.
For example, BPC-157 is a pentadecapeptide heavily investigated for angiogenic pathway upregulation and nitric oxide synthase (NOS) modulation in connective tissue and gastric mucosal repair. Larazotide (AT-1001) acts as a synthetic tight junction regulator that inhibits zonulin-mediated pathway disassembly, stabilizing intercellular gaps directly. Meanwhile, vasoactive intestinal peptide (VIP) operates via G-protein coupled receptors (VPAC1/VPAC2) to modulate systemic immune cell differentiation. Researchers comparing these mechanistic targets can explore detailed literature within our centralized research library.
Selecting the Right Format: 2mg vs. 10mg Mass Considerations
When designing experimental protocols, determining whether to source a 2mg vial or a larger 10mg mass specification depends on trial scale, assay duration, and budgetary logistics. A 2mg vial provides sufficient material for low-throughput screening, such as preliminary dose-response curves in 96-well cell culture plates or short-term pilot assays involving a small cohort of mice. Using 2mg vials prevents material waste when an assay requires fresh reconstitution for every test iteration.
Conversely, medium- to high-throughput research—such as multi-week animal studies, daily dosing protocols across several experimental arms, or high-volume ELISA validation—generally requires larger mass fills. Ordering KPV 10mg vials offers operational efficiency, reducing the frequency of reconstitution events and maintaining inter-assay consistency across larger sample sizes. Laboratories planning extensive research campaigns can explore institutional purchasing workflows via our wholesale accounts portal.
Frequently Asked Questions
What is the physical state and target application of KPV 2mg?
KPV 2mg is supplied as a lyophilized (freeze-dried) sterile white powder containing the tripeptide Lysine-Proline-Valine. It is intended strictly for in vitro laboratory assays, cellular signaling research, and preclinical animal models examining anti-inflammatory and intestinal barrier mechanics.
How do I calculate a 1 mg/mL solution from a 2mg KPV vial?
To yield a 1.0 mg/mL (1.0 µg/µL) concentration, reconstitute the 2mg lyophilized cake with exactly 2.0 mL of sterile diluent (such as Bacteriostatic Water or 0.9% Sodium Chloride). Use an accurate micropipette and gentle axial rotation to fully dissolve the powder.
Does PX1 Research provide lot-specific COAs for KPV?
Yes. Every batch of KPV manufactured by PX1 Research undergoes third-party HPLC and LC-MS testing to confirm purity (>98%) and exact molecular weight, alongside endotoxin testing. Lot-matched Certificates of Analysis are publicly accessible on our COA page.
What diluent should be used for cell culture applications?
For sensitive cell culture or tissue-based in vitro assays, sterile 0.9% Sodium Chloride or standard culture media is typically preferred to avoid introducing preservatives like benzyl alcohol into live-cell environments.
What is the recommended storage temperature for reconstituted KPV?
Reconstituted KPV should be aliquoted into low-binding microcentrifuge tubes and stored at -80°C for long-term stability. Short-term storage (up to 7-14 days) at 4°C is acceptable when reconstituted with bacteriostatic water.
Is KPV 2mg approved for human consumption or therapeutic use?
No. All products sold by PX1 Research, including KPV 2mg and KPV 10mg, are designated strictly for laboratory research use only. They are not for human, veterinary, clinical, or therapeutic applications.
What biological pathways does KPV target in preclinical research?
Preclinical data show that KPV enters cells via the PEP11 transporter and inhibits NF-κB p65 nuclear translocation, resulting in down-regulation of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
What should I do if the 2mg vial size is currently unavailable?
If the 2mg fill size is temporarily out of stock or reserved for custom institutional orders, PX1 Research stocks the KPV 10mg vial size, which offers identical molecular purity (>98%) and lot-matched analytical validation.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.